Editors' ChoiceCancer

A new hope for KRAS mutant cancers

See allHide authors and affiliations

Science Translational Medicine  21 Feb 2018:
Vol. 10, Issue 429, eaas8964
DOI: 10.1126/scitranslmed.aas8964

You are currently viewing the abstract.

View Full Text

Abstract

c-RAF ablation in KRAS mutant lung tumors is highly efficacious, supporting the development of selective c-RAF inhibitors for clinical use.

View Full Text